5:19 PM
 | 
Dec 16, 2011
 |  BC Extra  |  Company News

Takeda will not market peginesatide in Japan; Affymax falls

Affymax Inc. (NASDAQ:AFFY) fell $0.88 (12%) to $6.34 on Friday after partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) decided not to commercialize anemia product peginesatide in Japan. The partners said in a statement...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >